Mitochondria-Augmented Immune Cells for CAR-T Exhaustion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer therapies, particularly CAR-T cell treatments, face challenges such as T cell exhaustion, senescence, and limited durability and potency, which hinder effective tumor targeting and immune response in both hematological and solid tumors, along with inefficiencies in autoimmune disease management due to impaired immune cell function and metabolism.
Innovation Solution
The use of mitochondria-enhanced immune cells, including CAR-T cells, NK cells, and regulatory T cells, augmented with viable respiration-competent mitochondria to enhance metabolic activity, survival, and cytolytic function, thereby overcoming T cell exhaustion and senescence, and improving immune response efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional CAR-T cell therapy is used, then immune response is activated, but T cell exhaustion and senescence occur leading to limited durability and potency
Solution Approach 1:
The patent applies preliminary action by pre-augmenting T cells with mitochondria before they encounter the tumor microenvironment. This advance preparation enhances their metabolic capacity and survival capabilities, allowing them to resist exhaustion and maintain potency throughout the therapeutic duration, thereby resolving the contradiction between initial activation and long-term durability
Solution Approach 2:
The patent changes the metabolic parameters of T cells by introducing mitochondria that alter oxygen consumption rates and metabolic activity. This parameter transformation enables T cells to sustain higher functional levels for extended periods, overcoming the natural decline in survival time and durability that occurs with conventional therapy
2Power
If immune cells are activated to attack tumors, then cytolytic activity increases, but metabolic demand exceeds supply leading to cell exhaustion
Solution Approach 1:
The patent uses copying by introducing additional mitochondria into T cells, effectively duplicating the energy-producing machinery. This increases the metabolic capacity to match the high energy demands of activated cytolytic function, allowing sustained power output without exhaustion from metabolic imbalance
Solution Approach 2:
The patent creates a composite cellular structure by combining T cells with enhanced mitochondrial content. This composite approach integrates superior metabolic components into the immune cells, enabling them to sustain high cytolytic activity by combining the cytotoxic machinery with enhanced energy production systems
3Quantity of substance
If T cells are expanded ex vivo, then quantity of effector cells increases, but metabolic stress and senescence accelerate reducing quality and function
Solution Approach 1:
The patent applies preliminary action by pre-augmenting T cells with mitochondria during the ex vivo expansion process. This early intervention protects cells from metabolic stress that normally accelerates senescence during expansion, allowing large quantities of high-quality cells to be produced without the functional degradation that typically occurs
Solution Approach 2:
The patent provides beforehand cushioning by equipping T cells with enhanced mitochondrial reserves before they undergo expansion stress. This metabolic buffer protects the cells from the metabolic damage that would otherwise accumulate during large-scale expansion, preserving their functional quality while increasing their quantity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The augmentation of immune cells with mitochondria leads to increased basal and maximal oxygen consumption, enhanced metabolic activity, and prolonged survival, resulting in improved cytolytic activity and reduced exhaustion, thereby enhancing therapeutic efficacy against cancer and autoimmune diseases.
Implementation Method 1
increased basal and maximal oxygen consumption
Implementation Method 2
viable respiration-competent mitochondria capable of enhancing or expanding an immune cell
Data Source
AI summary
The disclosure relates to mitochondria-enhanced stem and immune cells, their compositions and therapeutic use.